|
|
Article: Genentech rejects bid by Roche
- Article from:
- Oakland Tribune
- Article date:
- August 13, 2008
- Author:
-
|
Copyright informationCopyright 2008 Oakland Tribune. Provided by ProQuest LLC. (Hide copyright information)
|
Genentech Inc. rejected Roche Holding AG's $43.7 billion takeover
bid, as Genentech shares closed 11 percent higher than the offer.
The biotechnology company said it was open to further talks.
Roche, of Basel, Switzerland, said July 21 it would pay $89 a
share for the 44 percent of South San Francisco-based Genentech it
doesn't already own. The offer "substantially undervalues the
company," a committee of Genentech directors said Wednesday in a
statement. Investors have said it could take a bid as high as $125 a
share to purchase the company.
The offer has been criticized by investors who say Roche, the
world's largest maker of cancer drugs, was trying to get a bargain.
Genentech's top ...
Related newspaper, magazine, and journal articles:
|